Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustryCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Verona Pharma (VRNA) Debt to Equity (2019 - 2025)

Verona Pharma (VRNA) debt to equity from Dec 31, 2019 to Jun 30, 2025. The current Verona Pharma (VRNA) debt to equity is 87.12%. You can export chart.

Debt to Equity

Debt to Equity

Annual Debt to Equity change of Verona Pharma (VRNA)

YearDebt to EquityChange
202458.83%
+203.18%
202319.40%
+357.73%
20224.24%
+28.84%
20213.29%
+31.08%
20202.51%
N/A
20190.00%
N/A

Comparison Verona Pharma (VRNA) debt to equity with competitors

Verona Pharma (VRNA) debt to equity is 87.12%.

TickerNameDebt to EquityUpside
DRUGBright Minds Biosciences Inc0.03%-99.97%
CMNDClearmind Medicine Inc0.10%-99.89%
ARVNArvinas Inc0.13%-99.85%
GHRSGH Research PLC0.16%-99.81%
ATHEAlterity Therapeutics Ltd0.18%-99.79%
CGONCg Oncology Inc0.27%-99.68%
PHVSPharvaris NV0.31%-99.64%
OSRHBellevue Life Sciences Acquisition Corp0.37%-99.58%
GLPGGalapagos NV0.37%-99.57%
VTVTvTv Therapeutics Inc - Class A0.46%-99.47%
LPTXLeap Therapeutics Inc0.68%-99.22%
ADXNAddex Therapeutics Ltd0.73%-99.16%
CBUSCibus Global Ltd. Class A0.75%-99.14%
ABVCABVC BioPharma Inc0.82%-99.05%
COEPCoeptis Therapeutics Holdings Inc. Common Stock0.87%-99.00%
PPCBPropanc Biopharma Inc1.05%-98.79%
ARGXArgen X SE1.14%-98.69%
OCSOculis Holding AG1.14%-98.69%
XRTXXORTX Therapeutics Inc1.17%-98.65%
IMMPImmutep Ltd1.22%-98.60%
CANFCan-Fite Biopharma Ltd1.27%-98.54%
RVPHReviva Pharmaceuticals Holdings Inc1.33%-98.48%
BNTXBioNTech SE1.62%-98.14%
NBPNovaBridge Biosciences.1.74%-98.00%
NRXSNeuraxis Inc1.75%-97.99%
IMABI-Mab1.77%-97.97%
IFRXInflaRx N.V.2.23%-97.44%
ENTOEntero Therapeutics, Inc. Common Stock2.51%-97.12%
GANXGain Therapeutics Inc2.67%-96.94%
NCNANuCana plc3.04%-96.51%
SXTP60 Degrees Pharmaceuticals Inc3.29%-96.23%
IMTXImmatics N.V3.31%-96.20%
YMABY-Mabs Therapeutics Inc3.66%-95.80%
IRONDisc Medicine Inc4.27%-95.10%
BDRXBiodexa Pharmaceuticals Plc4.38%-94.97%
SVASinovac Biotech Ltd4.55%-94.78%
LGVNLongeveron Inc - Class A4.67%-94.64%
MOLNMolecular Partners AG4.89%-94.39%
NCELNLS Pharmaceutics Ltd4.90%-94.38%
ADAGAdagene Inc5.23%-93.99%
PRTCPureTech Health plc American Depositary Shares5.56%-93.61%
ALXOAlx Oncology Holdings Inc5.62%-93.54%
REGNRegeneron Pharmaceuticals Inc6.32%-92.74%
ANROAlto Neuroscience Inc6.58%-92.44%
MDXGMimedx Group Inc7.24%-91.69%
GDTCCytoMed Therapeutics Ltd7.37%-91.54%
MRNAModerna Inc7.96%-90.86%
QLGNQualigen Therapeutics, Inc. Common Stock8.40%-90.36%
BEAMBeam Therapeutics Inc8.60%-90.12%
PBYIPuma Biotechnology Inc8.79%-89.91%
PYPDPolypid Ltd9.00%-89.66%
KURAKura Oncology Inc9.04%-89.63%
SLNOSoleno Therapeutics Inc10.06%-88.45%
RIGLRigel Pharmaceuticals11.25%-87.08%
MAZEMaze Therapeutics Inc11.36%-86.96%
ABEOAbeona Therapeutics Inc12.48%-85.68%
CLDICalidi Biotherapeutics Inc12.62%-85.51%
ASBPAspire Biopharma Holdings Inc12.90%-85.19%
ACIUAC Immune SA13.65%-84.33%
MNMDMind Medicine (MindMed) Inc. Common Shares14.62%-83.22%
VERAVera Therapeutics Inc - Class A15.01%-82.77%
ALTAltimmune Inc15.25%-82.50%
NUVBNuvation Bio Inc - Class A16.62%-80.92%
SVRASavara Inc17.08%-80.40%
ACHVAchieve Life Sciences Inc17.21%-80.24%
DYNDyne Therapeutics Inc17.27%-80.18%
HRMYHarmony Biosciences Holdings Inc17.45%-79.98%
SPRBSpruce Biosciences Inc18.66%-78.59%
RCUSArcus Biosciences Inc19.08%-78.09%
INVAInnoviva Inc19.24%-77.92%
MDWDMediWound Ltd19.62%-77.48%
TARSTarsus Pharmaceuticals Inc20.80%-76.12%
XNCRXencor Inc21.05%-75.84%
MESOMesoblast Ltd21.45%-75.38%
TCRXTscan Therapeutics Inc22.51%-74.17%
APLSApellis Pharmaceuticals Inc22.59%-74.07%
REPLReplimune Group Inc22.62%-74.03%
CNTACentessa Pharmaceuticals plc22.66%-73.99%
BMRNBiomarin Pharmaceutical Inc23.02%-73.57%
TSHATaysha Gene Therapies Inc23.10%-73.48%
FBIOFortress Biotech Inc23.12%-73.46%
HYFTMindWalk Holdings Corp23.71%-72.78%
ONCBeiGene Ltd24.13%-72.30%
LXRXLexicon Pharmaceuticals Inc24.49%-71.89%
NKTRNektar Therapeutics24.89%-71.43%
ICCCImmucell Corp29.87%-65.72%
CRSPCRISPR Therapeutics AG32.27%-62.96%
ZLABZai Lab Ltd32.30%-62.93%
QUREuniQure N.V.33.44%-61.62%
ABOSAcumen Pharmaceuticals Inc35.49%-59.26%
ALDXAldeyra Therapeutics Inc36.29%-58.34%
PRQRProQR Therapeutics N.V36.40%-58.21%
OBIOOrchestra BioMed Holdings Inc36.41%-58.20%
COGTCogent Biosciences Inc36.72%-57.85%
ELABPMGC Holdings Inc37.62%-56.82%
MLTXMoonLake Immunotherapeutics - Class A38.98%-55.26%
LEGNLegend Biotech Corp40.23%-53.82%
PHXMPHAXIAM Therapeutics SA ADR42.62%-51.07%
PHARPharming Group N.V.43.21%-50.41%
XFORX4 Pharmaceuticals Inc44.52%-48.89%
ADMAAdma Biologics Inc50.44%-42.11%
SRPTSarepta Therapeutics Inc55.69%-36.08%
BLRXBioline Rx Ltd55.78%-35.97%
ARQTArcutis Biotherapeutics Inc57.70%-33.77%
MDGLMadrigal Pharmaceuticals Inc62.62%-28.12%
CAICaris Life Sciences Inc - Class A64.29%-26.20%
SRRKScholar Rock Holding Corp71.23%-18.24%
INSMInsmed Inc76.93%-11.70%
ATAIATAI Life Sciences N.V.83.95%-3.64%
IONSIonis Pharmaceuticals Inc88.01%+1.02%
RYTMRhythm Pharmaceuticals Inc88.25%+1.30%
RPRXRoyalty Pharma plc - Class A90.13%+3.46%
CDXSCodexis Inc93.64%+7.48%
ALECAlector Inc94.08%+7.98%
GMABGenmab94.17%+8.10%
TTRXTurn Therapeutics Inc97.04%+11.39%
GERNGeron Corp109.92%+26.17%
XOMAXOMA Corp110.73%+27.10%
HCWBHCW Biologics Inc114.14%+31.01%
JAZZJazz Pharmaceuticals plc118.15%+35.61%
MRVIMaravai LifeSciences Holdings Inc - Class A119.30%+36.94%
TLXTelix Pharmaceuticals Ltd126.06%+44.70%
TGTXTG Therapeutics Inc127.78%+46.67%
ARDXArdelyx Inc136.94%+57.18%
FOLDAmicus Therapeutics Inc143.18%+64.35%
QNTMFSD Pharma Inc - Class B - Class B (Sub Voting)146.17%+67.78%
AAPGAscentage Pharma Group International149.47%+71.57%
OPTOpthea Ltd156.18%+79.27%
SPRYARS Pharmaceuticals Inc157.44%+80.71%
NMRANeumora Therapeutics Inc159.82%+83.45%
MISTMilestone Pharmaceuticals Inc161.42%+85.29%
CLLSCellectis181.25%+108.04%
ASNDAscendis Pharma A/S183.75%+110.92%
FTREFORTE SOFTWARE INC200.32%+129.94%
CELCCelcuity Inc257.58%+195.66%
HOWLWerewolf Therapeutics Inc262.95%+201.82%
VALNValneva SE273.15%+213.53%
ALLRAllarity Therapeutics Inc290.17%+233.07%
HUMAHumacyte Inc308.59%+254.22%
AXSMAxsome Therapeutics Inc344.13%+295.00%
ADAPAdaptimmune Therapeutics plc American Depositary Shares423.98%+386.66%
PGENPrecigen Inc462.16%+430.49%
OCGNOcugen Inc502.91%+477.26%
SNDXSyndax Pharmaceuticals Inc840.90%+865.22%
HALOHalozyme Therapeutics Inc976.45%+1020.81%
EDITEditas Medicine Inc1240.40%+1323.78%
RVNCRevance Therapeutics Inc1477.84%+1596.32%
IOBTIO Biotech Inc1829.20%+1999.62%